At a glance
ClinicalIndex Comparison RecordN/ACompleted· 51 enrolled
Drug / intervention
Self questionnaires of quality of life and living conditionsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer
In Brief
A clinical study evaluating Self questionnaires of quality of life and living conditions for Endometrial Cancer and 2 related conditions. Completed, enrolled 51 participants across 5 sites.
Detailed Summary
Through this study, The investigator believe to evaluate the impact in terms of overall quality of life of adjuvant chemotherapy in patients with locally advanced endometrial cancer at a distance from their care
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndometrial Cancer, Chemotherapy Effect, Quality of Life
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMar 2018
Enrollment StartMar 2018
Primary CompletionMar 2019
Study CompletionMar 2020
TodayJul 2026
First PostedMar 15, 2018
Enrollment StartMar 29, 2018
Primary CompletionMar 28, 2019
Study CompletionMar 28, 2020
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 8.3 years ago
Interventions
Self questionnaires of quality of life and living conditionsother
Patients will complete self-questionnaires of living conditions and quality of life (QLQ-C30; EN24; CIPN20; IPAQ; HADS)